dihydrokainate has been researched along with sb 203580 in 1 studies
Studies (dihydrokainate) | Trials (dihydrokainate) | Recent Studies (post-2010) (dihydrokainate) | Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) |
---|---|---|---|---|---|
180 | 0 | 46 | 3,489 | 4 | 1,137 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gong, SJ; Hu, YY; Li, WB; Sun, YW; Xian, XH; Zhang, JG; Zhang, LY; Zhang, M | 1 |
1 other study(ies) available for dihydrokainate and sb 203580
Article | Year |
---|---|
The p38 MAPK/NF-κB pathway mediates GLT-1 up-regulation during cerebral ischemic preconditioning-induced brain ischemic tolerance in rats.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Excitatory Amino Acid Transporter 2; Imidazoles; Ischemic Preconditioning; Kainic Acid; Male; MAP Kinase Signaling System; Neuroprotection; NF-kappa B; NF-kappa B p50 Subunit; Nitriles; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Wistar; Sulfones; Transcription Factor RelA | 2021 |